Ir para o conteúdo

Journal of Comparative Effectiveness Research

@journal-cer.bsky.social did:plc:4zeodn6prle4wch5ptr5knje

The latest CER, RWE & HEOR for patients, researchers, policy makers & all stakeholders | IF: 2.8 | MEDLINE-indexed | from Becaris Publishing

No Bluesky desde

Seguidores
38
Seguindo
27
Posts
105
Dias nos rankings
0

Resumo

Journal of Comparative Effectiveness Research (@journal-cer.bsky.social) é um usuário do Bluesky desde 16 dezembro 2024. Tem 38 seguidores, segue 27 contas e publicou 105 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • The Evidence Base@theevidencebase.bsky.social

    Why misaligned evidence strategies delay #PatientAccess to medicines | Becaris Publishing becarispublishing.com/digital-cont...

    Ver post
  • The Evidence Base@theevidencebase.bsky.social

    #RareDisease outcome assessment under #EUHTA and #JointClinicalAssessment | Becaris Publishing becarispublishing.com/digital-cont...

    Ver post
  • The Evidence Base@theevidencebase.bsky.social

    Hot off the press: Part one of our pick of articles within #HTA and #RWE published in January 2026 | Becaris Publishing becarispublishing.com/digital-cont...

    Ver post
  • The Evidence Base@theevidencebase.bsky.social

    Head-to-head real-world study reports overall survival advantage with apalutamide compared with darolutamide in metastatic castration-sensitive #ProstateCancer | Becaris Publishing becarispublishing.com/digital-cont...

    Ver post
  • The Evidence Base@theevidencebase.bsky.social

    #IndustryUpdate tracker: January 2026 | Becaris Publishing becarispublishing.com/digital-cont...

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.